Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Interventions
DRUG

Aripiprazole Once-Monthly (AOM)

Dosage and frequency of AOM administration individualized for each study participant in accordance with investigators' clinical judgment.

Trial Locations (1)

K1Y 4E9

RECRUITING

Ottawa Hospital, Civic Campus, Ottawa

All Listed Sponsors
collaborator

Lundbeck Canada Inc.

INDUSTRY

lead

Otsuka Canada Pharmaceutical Inc.

INDUSTRY

NCT04907279 - Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) | Biotech Hunter | Biotech Hunter